Document Type
Article
Publication Date
January 2000
Journal
Lancet
Volume
355
Issue
9201
Abstract
A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.
